Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$14,765,549
+$452,243 QoQ
Shares Held
114,907
-3.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#603
of 3,766 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. MRK ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,765,549 | 114,907 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $14,313,306 | 118,990 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $13,394,228 | 127,249 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $13,056,989 | 155,570 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,315,480 | 193,475 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,088,989 | 212,667 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $34,076,873 | 342,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,192,688 | 301,098 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,078,718 | 299,505 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $40,026,768 | 303,348 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,664,827 | 382,176 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $40,198,679 | 390,468 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $46,820,645 | 405,760 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $44,527,087 | 418,527 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $51,125,204 | 460,795 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $37,353,516 | 433,738 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $35,599,058 | 390,469 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $26,437,658 | 322,214 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $25,472,453 | 332,365 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $26,004,583 | 346,220 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $21,466,955 | 278,466 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $25,092,465 | 306,754 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $24,348,904 | 293,537 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $24,414,095 | 315,713 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $21,593,893 | 280,659 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||